Literature DB >> 27794526

Association of UCP2 -866G>A Polymorphism With Nonalcoholic Fatty Liver Disease in Patients From North-West of Iran.

Fatemeh Mohseni1, Safar Farajnia2, Mahdieh Abbasalizad Farhangi3, Manouchehr Khoshbaten2, Mohammad-Asghari Jafarabadi4.   

Abstract

OBJECTIVE: To investigate the association of uncoupling protein-2 (UCP2) -866G > A gene polymorphism (rs659366) with nonalcoholic fatty liver disease (NAFLD).
METHODS: We performed a case-control study with a cohort of 75 patients with NAFLD (of Iranian ethnicity) and 76 healthy individuals of Iranian ethnicity. The UCP2 -866G > A polymorphism (rs659366) was determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: Patients with AA and AG genotypes were 71% and 68%, respectively, more likely to have NAFLD, compared with individuals with the GG genotype (reference group). In subjects with a GG genotype, serum triglyceride (TG) concentration was significantly higher in patients with NAFLD (P = .04). Serum alanine aminotransferase (ALT) concentrations in all 3 genotypes and serum aspartate aminotransferase (AST) concentrations in AG and GG genotypes of UCP2 gene polymorphism were significantly higher in patients (P <.05).
CONCLUSION: Our results revealed a modest modifier effect of -866G>A UCP2 polymorphism in patients with NAFLD. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anthropometric indices; biochemical parameters; nonalcoholic fatty liver disease (NAFLD); uncoupling protein 2 (UCP2) gene; –866G>A polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27794526     DOI: 10.1093/labmed/lmw052

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  2 in total

Review 1.  Association of uncoupling protein (Ucp) gene polymorphisms with cardiometabolic diseases.

Authors:  Anna E Pravednikova; Sergey Y Shevchenko; Victor V Kerchev; Manana R Skhirtladze; Svetlana N Larina; Zaur M Kachaev; Alexander D Egorov; Yulii V Shidlovskii
Journal:  Mol Med       Date:  2020-05-25       Impact factor: 6.354

2.  MiR-30e-UCP2 pathway regulates alcoholic hepatitis progress by influencing ATP and hydrogen peroxide expression.

Authors:  Xi Jin; Mo-Sang Yu; Yue Huang; Zun Xiang; Yi-Peng Chen
Journal:  Oncotarget       Date:  2017-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.